Document is current
Any future updates will be listed below
-
Authors
Chylinski, Krzysztof
Hubmann, Maria
Hanna, Ruth E.
Yanchus, Connor
Michlits, Georg
Uijttewaal, Esther C. H.
Doench, John https://orcid.org/0000-0002-3707-9889
Schramek, Daniel https://orcid.org/0000-0001-9977-2104
Elling, Ulrich https://orcid.org/0000-0002-4514-2809
- License Information
-
More Information
Article History
Received: 1 April 2019
Accepted: 7 November 2019
First Online: 29 November 2019
Competing interests
: K.C. is an inventor on CRISPR-Cas9 technology patent applications US20190062790A1, EP3375877A1; K.C., U.E., M.H., I.V.B., and M.B. filed a patent on the CRISPR-Switch method (EP3219799A1). J.D. consults for Tango Therapeutics and Foghorn Therapeutics. No further competing interests.
